Sign In
Buy DRIO
$6.81
+0.0441 (+0.651%)
At Close: Jul 17, 2026
Fortune 50 Employer Awards Dario Contract to Deliver AI-Powered Cardiometabolic Care Platform
07:30am, Thursday, 16'th Jul 2026
Contract award for over 100,000 eligible employees marks Dario's fifth Fortune 50 client, further reflecting growing demand among large employers for integrated, outcomes-driven chronic condition mana
Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15%
07:30am, Monday, 13'th Jul 2026
DarioIQ drives higher engagement and retention, better clinical outcomes, higher client ROI and recurring revenue growth for Dario Dario IQ's AI-driven personalization increases member engagement by 4
Agreement representative of Dario's channel-led growth strategy to bring cardiometabolic digital health solution at scale to self-insured employers seeking measurable reductions in cardiometabolic ris
Top National Health Plan Extends Agreement for Mental Health and Expands Dario Partnership into Cardiometabolic Care, Demonstrating Successful
Third health plan customer to expand beyond initial deployment, reinforcing Dario's land-and-expand strategy and creating significant opportunity to grow revenue within existing customer base NEW YORK
O'Reilly's extensive experience across healthcare compliance, risk management, regulatory oversight and payer operations expected to support Dario's continued expansion with health plans, employers an
Dario Announces Strategic Collaboration with Beluga Health to Deliver Provider-Backed, Integrated Care at Scale
07:00am, Monday, 29'th Jun 2026
Dario's best-in-class, consumer-centric chronic care platform, combined now with Beluga's embedded clinical delivery, extends member engagement to include provider-delivered treatment, lowering costs
DarioHealth (DRIO) Upgraded to Buy: Here's Why
01:01pm, Wednesday, 17'th Jun 2026
DarioHealth (DRIO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Data from a total of 27 studies presented at ADA over 8 years reinforce Dario's strategic move closer to care, expanding revenue model into claims-based and outcomes-driven payments serving health pla
Expansion driven by highly successful partnership based on Dario's consistent ability to engage members and deliver scalable value across cardiometabolic conditions NEW YORK, May 26, 2026 /PRNewswire/
DarioHealth Corp. (DRIO) Q1 2026 Earnings Call Transcript
11:40am, Wednesday, 13'th May 2026
DarioHealth Corp. (DRIO) Q1 2026 Earnings Call Transcript
DarioHealth Q1 Earnings Call Highlights
11:06am, Wednesday, 13'th May 2026
DarioHealth NASDAQ: DRIO reported sequential revenue growth for the second straight quarter while outlining plans to expand its digital health platform further into care delivery, management said on t
DarioHealth Corp. (DRIO) Reports Q1 Loss, Beats Revenue Estimates
08:27am, Wednesday, 13'th May 2026
DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.71. This compares to a loss of $1.2 per share a year ago.
DarioHealth Reports First Quarter 2026 Financial and Operating Results
06:30am, Wednesday, 13'th May 2026
First quarter 2026 revenues increased to $5.6 million, marking the second consecutive quarter of sequential growth Operating expenses decreased by 21% year-over-year and decreased by 8% quarter-over-q
DarioHealth to Report First Quarter 2026 Results on Wednesday, May 13, 2026
08:30am, Monday, 04'th May 2026
Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK, May 4, 2026 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital
